Submitted by Anonymous (not verified) on 19 June 2025 - 13:45
Human medicines European public assessment report (EPAR): Rizmoic, naldemedine, Date of authorisation: 18/02/2019, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rizmoic, naldemedine, Date of authorisation: 18/02/2019, Revision: 12, Status: Authorised